e-SPACE Heart Failure 2022

  • Published:  19 October 2022
  • Likes: 

    Heart Icon

    12

Up Next

e-SPACE Heart Failure 2022

  • Published:  19 October 2022
  • Likes: 

    Heart Icon

    12

Average (ratings)
No ratings
Your rating
Overview

e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.

 

Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.

 

For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
 

e-SPACE Heart Failure 2022 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Part 1

Day 1

13 sessions
Plenary Session 1: Implementing the 4 foundational therapies in clinical practice Watch now
Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) Watch now
Plenary Session 2: Managing your HF patients with comorbidities (part 1) Watch now
Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Meet the expert: Improving exercise capacity and quality of life in patients with heart failure – the role of intravenous iron therapy (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 3: Using SGLT2 in your patients: practical considerations Watch now
Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Watch now
Plenary Session 4: Managing your HF patients with comorbidities (part 2) Watch now
Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Watch now
Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor) Watch now
Plenary Session 5: Managing side effects of HF drugs Watch now
Meet the expert: Sex differences in advanced heart failure Watch now
Plenary Session 6: How to manage the obese patient with HF Watch now

Faculty Biographies

Yuhui Zhang

Yuhui Zhang

Dr Yuhui Zhang is vice director of the Heart Failure Center and HFCU at Beijing Fuwai hospital, National Center for Cardiovascular Diseases in China.

She is secretary-general of the Chinese Heart Failure Association, the China National Heart Failure Society, the National HF Quality Control, the HF Medical Consortium, the Heart Failure specialist center Project, the China International Heart Failure Congress and of the Heart Failure Forum of China Heart Congress.

Dr Yuhui Zhang is an Editorial Board member of Cardiac Failure Review and may be contactable here. 

View full profile
David Sim

David Sim

Consultant

Overview

Dr David Sim is a senior consultant in the cardiology department at the National Heart Centre in Singapore.

 

Academic History

  • Royal College of Physicians (UK) diploma, 2004
  • Masters of Medicine (Internal Medicine), National University of Singapore, 2004
  • Bachelor of Medicine and Surgery, National University of Singapore, 2004

 

Career Overview

Dr Sim is the director of both the heart failure programme and the clinical trial research office and plays an active role as coordinator in a number of major global heart failure trials. He is a committee member of the adult heart transplant programme in the NHCS and is the project director for the advanced care planning programme.1

He has worked as an associate professor at the…

View full profile
Giuseppe Rosano

Giuseppe Rosano

Consultant Cardiologist and Professor of Cardiology (Hon)

Giuseppe Rosano was born and raised in Vibo Valentia, Italy, where he developed an early interest in medicine and cardiovascular science. While detailed information about his family and early childhood is not widely published, his Italian background and international academic career reflect strong cultural roots combined with global engagement in cardiovascular medicine.

 

Academic History

Professor Rosano obtained his Medical Degree in Medicine and Surgery with full honours from La Sapienza University of Rome in 1988. He subsequently completed his specialisation in Cardiology in 1992. Following his clinical training, he pursued advanced academic and research qualifications in the United Kingdom, earning both an MSc and a PhD in Medical Sciences from Imperial College London. His postgraduate research focused on cardiovascular physiology and pharmacology, forming the foundation of his future work in heart failure and cardiac metabolism.

 

View full profile
Vijay Chopra

Vijay Chopra

Senior Director of Clinical Cardiology, Heart Failure and Research

Dr Vijay Chopra is the Senior Director of Clinical Cardiology, Heart Failure and Research in the Heart Failure Programme at the Max Super Specialty Hospital in Saket, New Delhi, India. He is considered a pioneer in preventive cardiology, and has worked extensively in the management of patients with advanced heart disease. He has been principal investigator of numerous international clinical trials. 

Dr Chopra's research interests include preventive cardiology, heart failures and advanced heart diseases. He was awarded the Kutumbiah Prize in Clinical Medicine from CMC Vellore in 1972. He founded the Heart Failure Association of India (HFAI), and served as its first president from 2014 - 2019. 

Dr Chopra has over 50 publications in peer-reviewed journals. 

Dr Vijay Chopra is an Editorial Board member of Cardiac Failure Review and may be contacted

View full profile

Béla Merkely

Head

View full profile
A John Camm

A John Camm

Professor of Clinical Cardiology

A. John Camm is a British cardiologist internationally recognised for his contributions to clinical cardiology and cardiac electrophysiology. He has spent the majority of his professional career in the United Kingdom and has been closely associated with St George’s, University of London, where he has lived and worked for many decades. Throughout his career, he has combined clinical practice, academic leadership, and international guideline development, becoming one of the most influential figures in modern arrhythmia management.

 

Academic History

Professor Camm undertook his medical education and postgraduate training in the United Kingdom, progressing through specialist training in internal medicine and cardiology before focusing on cardiac electrophysiology. He developed a strong academic foundation early in his career, which led to senior academic appointments in cardiovascular medicine.

He was appointed British Heart Foundation Professor of…

View full profile